Riptide Bioscience Wins Highest Award at Annual Defense Department Research Review

November 15, 2016

SAN FRANCISCO, CA. – Riptide Bioscience, Inc., today announced that it has won the Gold Award for Excellence at the 2016 Military Health Systems Research Symposium (MHSRS).

The Symposium is the US Defense Department's primary annual review of ongoing research, attracting thousands of participants and hundreds of scientific presentations. Riptide's presentation received the highest rating from among over 350 submissions relating to antimicrobial and anti-infective technology.

Riptide's presentation was entitled "Evaluation of Novel Antimicrobial Peptides as Topical Anti-Infectives with Broad-Spectrum Activity against Combat-Related Bacterial and Fungal Wound Infection." Dr. L. Edward Clemens, representing Riptide in presentation of the material at MHSRS, commented, "Our research demonstrated the striking efficacy of these engineered peptides against a wide variety of pathogens that can be debilitating or life-threatening following combat injuries."

Dr. Clemens presented the data jointly with Dr. Mina Izadjoo of Trideum Biosciences, a contractor to Riptide in evaluation of the proprietary peptides, under a $1.5 million grant from the Defense Department.

Dr. Kathryn Woodburn, Riptide Principal Scientist, commented, "We're excited that this work is opening a new and very promising therapeutic strategy, which should go a long way to address the growing problem of microbial resistance to conventional small-molecule drugs. That's of use not only on the battlefield, but in many clinical settings."

Riptide Bioscience, Inc., with laboratories in Vallejo, California, maintains an intensive program of research into peptide-based therapeutics. Contact:

Back to all news articles >